Intrinsiqq
Mobile-Health Network Solutions Inc. logo

Mobile-Health Network Solutions Inc. Quality Score

MNDR

⊜ Compare
Quality35

Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
0/100
-0.1x

Negative earnings, no valuation support

Cash Flow Multiple
0/100
-0.1x

Negative FCF, no valuation support

Revenue Growth
100/100
75.5%

Above 10% CAGR, strong compounder

Cash Flow Growth
0/100
Negative FCF

FCF negative, burning cash after capex

Business Quality & Capital Allocation

Share Dilution
100/100
-97.5%

Shrinking >2%, active buybacks

Margin Trend
0/100
-89.7pp

Contracted >2pp, margin pressure

Capital Structure
100/100
-$6M

Net cash position, no leverage concern

2021
$163180
$81717
2022
$10.0M
$59117
2023
$2.00M
$395783
2024
$7.00M
$376010
CashDebt
Return on Capital
0/100
-505.2%

Below 8%, may not cover cost of capital

Customize WeightsPremiumUpgrade

Mobile-Health Network Solutions (MNDR) quality: score, margins and returns

Mobile-Health Network Solutions (MNDR) scores 35/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100, on -112.4% operating margins and -505.2% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Mobile-Health Network Solutions (MNDR) a high-quality business?+

Mobile-Health Network Solutions scores 35 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a -112.4% operating margin and a -505.2% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Mobile-Health Network Solutions's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from MNDR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Mobile-Health Network Solutions scores well and where it falls behind.

What is Mobile-Health Network Solutions's return on invested capital (ROIC)?+

Mobile-Health Network Solutions earns about -505.2% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to MNDR's margins and growth on this scorecard to judge durability.

How profitable is Mobile-Health Network Solutions?+

Mobile-Health Network Solutions runs an operating margin of about -112.4% and a net margin of about -111.7%. Revenue has grown at roughly 75.5% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Health Information Services · Pick stocks to compare with MNDR

CompareIntrinsic value
PMED.XSTOPeptonic Medical AB
€0.00+0.00%0
ALVMG.XPARVisiomed Group SA
€0.15+7.81%19
S2M.XSTOS2Medical AB
€0.00+0.00%40
HKPDCellyan Biotechnology Co., Ltd
$1.85-4.64%18
PANG.XMADPangaea Oncology S.A.
€1.47+0.00%30
ALGAE.XPARFermentalg S.A.
€0.37-5.38%40
IMMPImmutep Ltd. ADR
$2.95-1.67%40
MOB.XSTOMoberg Pharma AB
€0.94-5.35%40

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing MNDR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.